Interestingly, these studies suggest an age-related increase in plasma IGFBP-2 levels, particularly in individuals over 50, which parallels the development of insulin resistance and may serve as a mortality predictor after adjusting for insulin sensitivity [52]. This evidence concerns the gene IGFBP2 and Insulin resistance.